These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26336946)

  • 1. Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women.
    Kuhns LM; Reisner SL; Mimiaga MJ; Gayles T; Shelendich M; Garofalo R
    AIDS Behav; 2016 Jul; 20(7):1470-7. PubMed ID: 26336946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of Antiretroviral Pre-exposure Prophylaxis from a Cohort of Sexually Experienced Young Transgender Women in Two U.S. Cities.
    Restar AJ; Kuhns L; Reisner SL; Ogunbajo A; Garofalo R; Mimiaga MJ
    AIDS Behav; 2018 Nov; 22(11):3649-3657. PubMed ID: 29713838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and Barriers to Participation in PrEP HIV Prevention Trials Involving Transgender Male and Female Adolescents and Emerging Adults.
    Fisher CB; Fried AL; Desmond M; Macapagal K; Mustanski B
    AIDS Educ Prev; 2017 Jun; 29(3):205-217. PubMed ID: 28650227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure Prophylaxis Awareness and Use Among Transgender and Nonbinary Individuals in Canada.
    Hallarn J; Scheim AI; Bauer GR
    J Acquir Immune Defic Syndr; 2024 Aug; 96(4):341-349. PubMed ID: 38916428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials.
    Wood SM; Morales KH; Metzger D; Davis A; Fiore D; Petsis D; Barnett K; Koenig HC; Dowshen N; Gross R; Frank I
    AIDS Behav; 2021 Feb; 25(2):524-531. PubMed ID: 32860114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Evaluation of TransLife Care: A Locally Developed Structural HIV Prevention Intervention for Transgender Women in Chicago, Illinois.
    Kuhns LM; Perloff J; Johnson AK; Paul JL; Pleasant K; Evans K; Denson DJ; Gelaude DJ; Bessler PA; Cervantes M; Muldoon AL; Garofalo R; Hotton AL
    AIDS Educ Prev; 2024 Jun; 36(3):155-167. PubMed ID: 38917300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Locally Developed Interventions to Promote PrEP Among Racially/Ethnically Diverse Transgender Women in the United States: A Unique CDC Initiative.
    Rhodes SD; Kuhns LM; Alexander J; Alonzo J; Bessler PA; Courtenay-Quirk C; Denson DJ; Evans K; Galindo CA; Garofalo R; Gelaude DJ; Hotton AL; Johnson AK; Mann-Jackson L; Muldoon A; Ortiz R; Paul JL; Perloff J; Pleasant K; Reboussin BA; Refugio Aviles L; Song EY; Tanner AE; Trent S
    AIDS Educ Prev; 2021 Aug; 33(4):345-360. PubMed ID: 34370565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Mistrust and PrEP Perceptions Among Transgender Women: A Cluster Analysis.
    D'Avanzo PA; Bass SB; Brajuha J; Gutierrez-Mock L; Ventriglia N; Wellington C; Sevelius J
    Behav Med; 2019; 45(2):143-152. PubMed ID: 31343968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Engsig FN; Kronborg G
    Ugeskr Laeger; 2024 May; 186(19):. PubMed ID: 38808765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the social and structural context of oral PrEP delivery: an ethnography exploring barriers and facilitators impacting transgender women who engage in street-based sex work in Baltimore, Maryland.
    Cooney EE; Footer KHA; Glick JL; Passaniti A; Howes M; Sherman SG
    AIDS Res Ther; 2023 Sep; 20(1):69. PubMed ID: 37730616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting a Group-Level PrEP Promotion Intervention Trial for Transgender Latinas During the COVID-19 Pandemic.
    Rhodes SD; Tanner AE; Mann-Jackson L; Alonzo J; Refugio Aviles L; Galindo CA; Bessler PA; Courtenay-Quirk C; Smart BD; Garcia M; Goldenberg T; Sucaldito AD; Reboussin BA
    AIDS Educ Prev; 2022 Dec; 34(6):481-495. PubMed ID: 36454131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Latent Class Analysis of Chronic Health Conditions Among HIV-Positive Transgender Women of Color.
    Swartz JA; Ducheny K; Holloway T; Stokes L; Willis S; Kuhns LM
    AIDS Behav; 2021 Jul; 25(Suppl 1):52-63. PubMed ID: 31144132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women-Centered Program for Women of Color (WC4WC): A Community-Based Participatory, Culturally Congruent Sexual Health Intervention in Los Angeles County, California.
    Wyatt GE; Chin D; Loeb TB; Norwood-Scott E; McEwan JA; Zhang M; Smith-Clapham AM; Cooley-Strickland M; Trinidad C; Flint JR; Wells Y; Divinity R; Liu H
    Am J Public Health; 2023 Jun; 113(S2):S110-S114. PubMed ID: 37339413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
    Sevelius JM; Keatley J; Calma N; Arnold E
    Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral Interventions to Prevent HIV Transmission and Acquisition for Transgender Women: A Critical Review.
    Garofalo R; Kuhns LM; Reisner SL; Mimiaga MJ
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S220-5. PubMed ID: 27429186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV prevention among transgender women in Latin America: implementation, gaps and challenges.
    Silva-Santisteban A; Eng S; de la Iglesia G; Falistocco C; Mazin R
    J Int AIDS Soc; 2016; 19(3 Suppl 2):20799. PubMed ID: 27431470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices.
    Radix A; Sevelius J; Deutsch MB
    J Int AIDS Soc; 2016; 19(3 Suppl 2):20810. PubMed ID: 27431475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric Diagnoses and Comorbidities in a Diverse, Multicity Cohort of Young Transgender Women: Baseline Findings From Project LifeSkills.
    Reisner SL; Biello KB; White Hughto JM; Kuhns L; Mayer KH; Garofalo R; Mimiaga MJ
    JAMA Pediatr; 2016 May; 170(5):481-6. PubMed ID: 26999485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Individual and Area Level Factors Between HIV-Infected Cisgender and Transgender Individuals in Florida (2006-2014).
    Fennie KP; Trepka MJ; Maddox LM; Lutfi K; Lieb S
    AIDS Behav; 2016 Oct; 20(10):2186-2191. PubMed ID: 26885811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of In-country and Cross-Border Mobility on Condom Use Among Transgender Women (hijras) in Bangladesh: A Cross-Sectional Study.
    Rana AKMM; Reza MM; Alam MS; Khatun M; Khan SI; Azim T
    AIDS Behav; 2016 Oct; 20(10):2165-2177. PubMed ID: 26837627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.